Stay updated on Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.

Latest updates to the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision label v3.5.4 is added to the study record history, indicating an update to the page's version history. The previous revision v3.5.3 is removed from the visible history.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry v3.5.3 was added to the Record History, and the previous revision entry v3.5.2 was removed, reflecting an update to the page's version history.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision v3.5.2 was added to the record history and revision v3.5.0 was removed.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded revision v3.5.0 and deleted revision v3.4.3 from the history.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry v3.4.3 is added to the record history, replacing the previous v3.4.2 entry.SummaryDifference0.1%

- Check112 days agoChange DetectedRevision: v3.4.2 added and a prior site-wide notice about funding (v3.4.1) removed. These updates are administrative and do not affect the study record content or essential navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

Stay in the know with updates to Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.